VBI Vaccines Inc (VBIV) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
VBI Vaccines Inc. has completed a $2 million registered direct offering, issuing over 2.2 million common shares and warrants at $0.88 each, with the warrants exercisable immediately at $0.76 and expiring in five years. The company, focused on immunology and vaccine development, plans to allocate the net proceeds for general corporate purposes and working capital. H.C. Wainwright & Co. served as the exclusive placement agent for the transaction.
For further insights into VBIV stock, check out TipRanks’ Stock Analysis page.